These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry. Foeldvari I, Becker I, Horneff G. Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824 [Abstract] [Full Text] [Related]
3. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VV, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG. Clin Exp Rheumatol; 2016 Nov; 34(4):714-8. PubMed ID: 27385618 [Abstract] [Full Text] [Related]
8. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. Papadopoulou C, Kostik M, Böhm M, Nieto-Gonzalez JC, Gonzalez-Fernandez MI, Pistorio A, Martini A, Ravelli A. J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559 [Abstract] [Full Text] [Related]
10. Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a cross-sectional analysis of a prospective nationwide study. Tappeiner C, Klotsche J, Schenck S, Niewerth M, Minden K, Heiligenhaus A. Clin Exp Rheumatol; 2015 Sep; 33(6):936-44. PubMed ID: 26517055 [Abstract] [Full Text] [Related]
15. [Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database]. Heiligenhaus A, Niewerth M, Mingels A, Ganser G, Thon A, Pleyer U, Greiner K, Minden K. Klin Monbl Augenheilkd; 2005 Dec; 222(12):993-1001. PubMed ID: 16418970 [Abstract] [Full Text] [Related]
16. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K. Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155 [Abstract] [Full Text] [Related]
18. Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ). Yasumura J, Yashiro M, Okamoto N, Shabana K, Umebayashi H, Iwata N, Okura Y, Kubota T, Shimizu M, Tomiita M, Nakagishi Y, Nishimura K, Hara R, Mizuta M, Yasumi T, Yamaide F, Wakiguchi H, Kobayashi M, Mori M. Pediatr Rheumatol Online J; 2019 Apr 11; 17(1):15. PubMed ID: 30975163 [Abstract] [Full Text] [Related]
19. Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. Beukelman T, Lougee A, Matsouaka RA, Collier D, Rumsey DG, Schenfeld J, Stryker S, Twilt M, Kimura Y, CARRA Registry Investigators. Pediatr Rheumatol Online J; 2021 Aug 21; 19(1):131. PubMed ID: 34419107 [Abstract] [Full Text] [Related]
20. A Nordic screening guideline for juvenile idiopathic arthritis-related uveitis. Leinonen S. Acta Ophthalmol; 2023 Jun 21; 101(4):465-468. PubMed ID: 36458735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]